Gamma-aminobutyric acid type A receptor alpha-1 beta-x gamma-2 benzodiazepine site (GABRA1-containing GABA_A receptor)

The GABA_A receptor benzodiazepine site on α1βxγ2-containing receptors is a high-affinity allosteric binding site located at the interface of the α1 and γ2 subunits within the pentameric GABA_A receptor complex (Sigel & Steinmann, 2012). These receptors are the most abundant GABA_A subtype in the mammalian central nervous system, particularly concentrated in the cerebral cortex, hippocampus, and cerebellum, where they mediate fast inhibitory neurotransmission (Rudolph & Knoflach, 2011). When benzodiazepines or non-benzodiazepine hypnotics (Z-drugs) bind to this site, they enhance the inhibitory effect of gamma-aminobutyric acid (GABA) by increasing the frequency of chloride channel opening, resulting in neuronal hyperpolarization (Tan et al., 2011). This specific α1-containing subtype is primarily responsible for the sedative, hypnotic, and anticonvulsant effects of these drugs, as well as their ability to induce anterograde amnesia (Olsen, 2018). Clinically, this site is a major target for treating insomnia and acute seizures, though its activation is also linked to side effects like daytime sleepiness and motor impairment. Chronic use of drugs targeting this site can lead to significant therapeutic challenges, including the development of tolerance, physical dependence, and a severe withdrawal syndrome upon discontinuation (StatPearls, 2023).

Other names

BZ1 receptorOmega-1 receptorα1βγ2 GABA-A receptorBenzodiazepine receptor type 1GABRA1-containing receptor

Positive allosteric modulation (PAM) at the α1/γ2 subunit interface. Binding increases the receptor's affinity for GABA, which increases the frequency of chloride channel opening, leading to post-synaptic hyperpolarization and reduced neuronal firing (Sigel & Steinmann, 2012; Olsen, 2018).